Treatment of hepatitis E virus

@article{Dalton2016TreatmentOH,
  title={Treatment of hepatitis E virus},
  author={H. Dalton and N. Kamar},
  journal={Current Opinion in Infectious Diseases},
  year={2016},
  volume={29},
  pages={639–644}
}
  • H. Dalton, N. Kamar
  • Published 2016
  • Medicine
  • Current Opinion in Infectious Diseases
  • Purpose of review Over the last 10 years, it has become apparent that hepatitis E virus (HEV) is a pathogen of global significance. In contrast to HEV in the developing world, HEV in developed countries is caused by HEV genotypes 3 and 4, which are enzoonotic with a porcine primary host and cause both acute and chronic infection. Chronic infection occurs in the immunosuppressed, including transplant recipients, and untreated can cause rapidly progressive cirrhosis. Recent findings Ribavirin has… CONTINUE READING
    Dosing ribavirin in hepatitis E‐infected solid organ transplant recipients
    • 6
    Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients
    • 6
    • Highly Influenced
    Hepatitis E virus replication and interferon responses in human placental cells
    • 18
    • PDF
    Hepatitis E virus (HEV)—The Future
    • 6
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 29 REFERENCES
    Hepatitis E virus and neurological injury
    • 123